(Q35218786)

7 August 2017

1 reference

title

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks (English)

1 reference

7 August 2017

1 reference

1 reference

2

Kelly K Hunt

1 reference

7 August 2017

5

Gabriel N Hortobagyi

1 reference

7 August 2017

Thomas A Buchholz

1

1 reference

7 August 2017

Gary J Whitman

series ordinal

3

1 reference

7 August 2017

Aysegul A Sahin

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

98

1 reference

7 August 2017

1150-1160

1 reference

7 August 2017

6

1 reference

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

7 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Effect of delay in radiation in the combined modality treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Global gene expression changes during neoadjuvant chemotherapy for human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Consensus Statement on postmastectomy radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Controversies regarding the use of radiation after mastectomy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11603

7 January 2021

Identifiers

DOI

10.1002/CNCR.11603

1 reference

7 August 2017

1 reference